Impact of age at onset and newborn screening on outcome in organic acidurias
- 21 December 2015
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 39 (3), 341-353
- https://doi.org/10.1007/s10545-015-9907-8
Abstract
To describe current diagnostic and therapeutic strategies in organic acidurias (OADs) and to evaluate their impact on the disease course allowing harmonisation.Funding Information
- European Parliament (BE) (DG Sanco 2010 12 01)
This publication has 43 references indexed in Scilit:
- Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemiaOrphanet Journal of Rare Diseases, 2014
- Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models—a cohort study in 180 patientsJournal of Inherited Metabolic Disease, 2014
- Feeding difficulties in children with inherited metabolic disorders: a pilot studyJournal of Human Nutrition and Dietetics, 2012
- Clinical and neurocognitive outcome in symptomatic isovaleric acidemiaOrphanet Journal of Rare Diseases, 2012
- Propionic acidemia: neonatal versus selective metabolic screeningJournal of Inherited Metabolic Disease, 2011
- Glutaric aciduria type I: outcome following detection by newborn screeningJournal of Inherited Metabolic Disease, 2008
- Newborn screening for glutaric aciduria type I in Victoria: Treatment and outcomeMolecular Genetics and Metabolism, 2008
- ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long‐term outcome and effects of expanded newborn screening using tandem mass spectrometryJournal of Inherited Metabolic Disease, 2006
- Methylmalonic and propionic acidaemias: Management and outcomeJournal of Inherited Metabolic Disease, 2005
- A Common Mutation Is Associated with a Mild, Potentially Asymptomatic Phenotype in Patients with Isovaleric Acidemia Diagnosed by Newborn ScreeningAmerican Journal of Human Genetics, 2004